| RESEARCH ARTICLE |
|
| Year : 2009 | Volume
: 30
| Issue : 1 | Page : 22-28 |
|
|
A comparative drug trial on Santarpanottha Madhumeha Vishesha (Syndrome X)
Loknath Sharma1, Ish Sharma2
1 Professor & Head , PG Dept of Roga & Vikriti Vigyan, National Institute of Ayurveda, Jaipur, India
2 Lecturer, S.K.S.S. Ayurveda College, Ludhiana & S.S.M.D. Ayurveda College, Moga, Punjab, India
Correspondence Address:
Loknath Sharma
Professor & Head , PG Dept of Roga & Vikriti Vigyan, National Institute of Ayurveda, Jaipur
India
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
Syndrome-X has emerged as an area of special interest to medical faculty as it houses worst lifestyle pathologies in one patient. There being unknown common ground to Diabetes Mellitus, Hypertension, Obesity & dyslipidemia, the nomenclature adopted is Syndrome-X. As these diseases are observed to be led by Diabetes Mellitus, the other names of the syndrome are Metabolic Syndrome & Insulin resistant syndrome. This is why the Ayurvedic name attributed is 'Santarpanottha Madhumeha Vishesha'. The present study was aimed at observing & evaluating the common Nidana along with a comparative clinical study of two herbo-mineral compounds. 100 diagnosed patients of Syndrome-X were selected and randomly divided in two groups of fifty patients each; Group-A receiving Compound - A, Whereas Group-B receiving Compound - A with Medohara (Navak) Guggulu respectively. The vehicle for both the groups was Dashamoola decoction in a dose of 40 ml twice a day for 45 days. It was observed that most patients in group -B had significant improvement in Shrama, Prabhoot mootrata, Daurbalya, Vibandha, Kanthatalu shosha, Pipasadhikya & Sada. |
|
|
|
| [PDF]* |
|
 |
|
